How much revenue does Bharat Parenterals make?

Bharat Parenterals reported 3.43 billion INR in revenue for fiscal year 2026. In Q1 2027 revenue was 937.37 million INR.

What companies are similar to Bharat Parenterals?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Indoco Remedies Limited (INDOCO.NS), Sakar Healthcare Limited (SAKAR.NS), Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS), Lincoln Pharmaceuticals Limited (LINCOLN.NS).

Bharat Parenterals Ltd (BPLPHARMA.BO) Stock

About Bharat Parenterals Ltd

Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally. The company provides antibiotics, cardiovascular and central nervous system, antifungal, antimalarial, gastrointestinal tract/alimentary systems, analgesics, anaesthetics, quinolones, erectile dysfunction medicines, nutrition...

At a glance

Bharat Parenterals reported revenue of 3.43 billion INR for fiscal year 2026, and net income of -81.88 million INR. In Q1 2027 (the quarter ended June 30, 2026) revenue was 937.37 million INR, down 19.2% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2026.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.